Abstract:Total parenteral nutrition (TPN) is provided to patients undergoing allogenic hematologic stem cell transplantation (allo-HSCT) to help minimize nutritional consequences of both conditioning regimens as well as complications resulting from the procedure such as GVHD, VOD and so on, and glutamine could to improve the clinical course of patients after transplantation while given with parenteral nutrition as it is considered that it has stimulatory effects on lymphocytes and mucosa cells in vitro. In the study, we investigated the effect of dipeptiven, N(2)-L-Alanyl-L-Glutamine, which has dipeptides as free glutamine is rather unstable and poorly soluble, added to standard TPN preparations on complication and recovery of patients with allo-HSCT. 40 patients who suffered hematologic malignancies and received allo-HSCT were randomly assigned to receive either standard TPN (control group, n=20), or dipeptiven supplemented TPN (DPT group, n=20). The Bu/Cy2 regimen was used in conditioning with Bu (16mg/kg) plus Cy (120mg/kg) and all patients were given mycophenolate mofetil, CsA and MTX to prevent GVHD. The nutritiona support was started about 1 to 12 days after transplantation and 1.5ml/kg.d dipeptiven was added to the DPT group. During the period of nutritiona support, serum albumin, total protein, creatinine, total bilirubin, leukocytes, lymphocytes were monitored, and time to neutrophil engraftment, decrease of body weight, hospital stays, and other data related to hospital infection and acute GVHD were evaluated for all patients. As a result, the levels of serum albumin fell in the two groups on the 7-day, but on the 28-day those in the DPT group returned to normal and were significantly better than those in the control group (P<0.05). The total bilirubin and creatinine concentration did not change much. And lymphocytes of the patients in the DPT group recovered more rapidly than in the control group (P<0.05). There were less cases with clinical infection and microbial colonization in the DPT group than the control group (10 vs 16,11 vs 17, P<0.05). Also days for antibiotic requirements, days of diarrhea, changes of body weight and hospital stays reduced in the DPT group (16.5±10.6d vs 25.4±16.3d, 4.7±4.5d vs 8.2±6.0d, 2.0±2.0kg vs 3.3±1.6kg, 49.2±18.8d vs 58.0±20.2d, P<0.05, respectively). There were no different between the two groups of incidence of acute GVHD. In the conclusion, DPT-supplemented parenteral nutrition was beneficial in allo-HSCT patients for the nutritional status improving, the incidence of infection and damage of intestine, liver diminishing were all reduced, and the incidence of acute GVHD not increasing.

Randomizedly controlled trial on application of parenteral alanyl-glutamine dipeptide in chemotherapy of advanced patients with esophageal and cardiac carcinoma

The Effect of Dipeptiven in Patients after Allogenic Hematologic Stem Cell Transplantation.

Effects of alanyl-glutamine dipeptide administration on postoperative intestinal permeability and systemic inflammatory response

Effects of alanyl-glutamine dipeptide on postoperative intestinal permeability and stress response

Effects of alanyl-glutamine dipeptide administration on postoperative intestinal permeability and immmunologic function

The Effect of Alanyl-glutamine Supplement Parenteral Nutrition on Patients' Body Immune and Nutrition with Esophageal Carcinoma During Postoperation

Oral Glutamine Ameliorates Chemotherapy-Induced Changes of Intestinal Permeability and Does Not Interfere with the Antitumor Effect of Chemotherapy in Patients with Breast Cancer: a Prospective Randomized Trial.

Effect of intra-venous dipetide Ala-Gln on the severity of EN related diarrhea in aged patients

Molecular Dissection of Mycobacterium tuberculosis Integration Host Factor Reveals Novel Insights into the Mode of DNA Binding and Nucleoid Compaction.

Clinical Study of Glutamine Combined with Early Enteral Nutrition Support on Nutritional Status of Gastric Cancer Patients Undergoing Neoadjuvant Chemotherapy

Expert consensus on clinical application of intravenous alanyl-glutamine dipeptide

A Prospective Study to Evaluate the Efficacy and Safety of Oral Acetyl-L-carnitine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy.

Efficacy of vitamin C on chemotherapy-related anemia in pancreatic cancer: study protocol for a randomized controlled trial

Effects of Yipi Huayu decoction on tumor markers, immune function, and adverse reactions during chemotherapy in gastric cancer patients: a retrospective propensity score-matched study

Search for high energy gamma rays from the spontaneous fission of 252Cf.

Effect of alanyl-glutamine on nutrition and immune in patients with respiratory failure

A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm

Effects of pharmaceutical intervention on rational clinical use of alanyl-glutamine

Effect of Glutathione Support on Changes of Perioperative Amino Acids Profile in Patients with Gastric Cancer

The randomized controlled trial of amifostine in improving neurotoxicity induced by oxaliplatin on gastroenteric tumor patients

Study of Body Composition Changes of Neoadjuvant Chemotherapy in the Advanced Gastric Cancer